Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Fractyl Health Inc. currently has 3 pending office actions in the Medical Devices & Mechanical Engineering technology area. These 3 actions are distributed across 3 distinct art units, indicating that each case falls into a different technical sub-category. Furthermore, the 3 actions are being reviewed by 3 distinct examiners, so every pending case has a unique reviewer.
IGBOKO, CHIMA U is the busiest examiner for this portfolio, currently managing 1 pending office action. This 1 action is the maximum number assigned to any single examiner for the company. With 3 distinct examiners and 3 distinct art units for only 3 pending office actions, the prosecution is highly fragmented across different specialized groups and individuals. Practitioners should be prepared for three completely different examination experiences, as there is no overlap in examiners or art units for the 3 pending office actions. The busiest examiner, IGBOKO, CHIMA U, only handles 1 of the 3 actions, meaning no single person has a broad view of the company's active Medical Devices & Mechanical Engineering portfolio.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| §102 only | 1 (33%) |
| §112 only | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| IGBOKO, CHIMA U | 1 | 78.6% | +39.8% |
| GEDEON, BRIAN T | 1 | 86.9% | +7.2% |
| DANIEL, ANTARIUS S | 1 | 52.1% | +15.7% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18741667 | METHODS AND SYSTEMS FOR TREATING MUCOSAL DYSFUNCTION AND OTHER MEDICAL CONDITIONS OF A PATIENT | GEDEON, BRIAN T | 8d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18957555 | TISSUE EXPANSION DEVICES, SYSTEMS AND METHODS | IGBOKO, CHIMA U | 15d overdue |
| 17721937 | SYSTEMS, DEVICES AND METHODS FOR PERFORMING MEDICAL PROCEDURES IN THE INTESTINE | DANIEL, ANTARIUS S | — |
| Art Unit | Apps |
|---|---|
| 3771 | 1 |
| 3796 | 1 |
| 3783 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18957555 | TISSUE EXPANSION DEVICES, SYSTEMS AND METHODS | IGBOKO, CHIMA U | 3771 | §112 | Final Rejection | 15d overdue | Pending | Nov 22, 2024 |
| 18741667 | METHODS AND SYSTEMS FOR TREATING MUCOSAL DYSFUNCTION AND OTHER MEDICAL CONDITIONS OF A PATIENT | GEDEON, BRIAN T | 3796 | §102 | Final Rejection | 8d overdue | Pending | Jun 12, 2024 |
| 17721937 | SYSTEMS, DEVICES AND METHODS FOR PERFORMING MEDICAL PROCEDURES IN THE INTESTINE | DANIEL, ANTARIUS S | 3783 | §103 | Non-Final OA | — | Pending | Apr 15, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial